357 related articles for article (PubMed ID: 15944216)
1. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.
Azziz R; Marin C; Hoq L; Badamgarav E; Song P
J Clin Endocrinol Metab; 2005 Aug; 90(8):4650-8. PubMed ID: 15944216
[TBL] [Abstract][Full Text] [Related]
2. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
Elife; 2023 Aug; 12():. PubMed ID: 37534878
[TBL] [Abstract][Full Text] [Related]
3. Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences.
Riestenberg C; Jagasia A; Markovic D; Buyalos RP; Azziz R
J Clin Endocrinol Metab; 2022 Jan; 107(2):575-585. PubMed ID: 34546364
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study.
Ding T; Hardiman PJ; Petersen I; Baio G
Hum Reprod; 2018 Jul; 33(7):1299-1306. PubMed ID: 29684121
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
Sirmans SM; Parish RC; Blake S; Wang X
J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on Polycystic Ovary Syndrome: Is Polycystic Ovary Syndrome Research Underfunded?
Brakta S; Lizneva D; Mykhalchenko K; Imam A; Walker W; Diamond MP; Azziz R
J Clin Endocrinol Metab; 2017 Dec; 102(12):4421-4427. PubMed ID: 29092064
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of polycystic ovary syndrome.
Trivax B; Azziz R
Clin Obstet Gynecol; 2007 Mar; 50(1):168-77. PubMed ID: 17304034
[TBL] [Abstract][Full Text] [Related]
9. The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966.
West S; Vähäsarja M; Bloigu A; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Corbett S; Vääräsmäki M; Morin-Papunen L
Hum Reprod; 2014 Mar; 29(3):628-33. PubMed ID: 24324025
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008.
Okoroh EM; Hooper WC; Atrash HK; Yusuf HR; Boulet SL
Am J Obstet Gynecol; 2012 Oct; 207(4):299.e1-7. PubMed ID: 22921097
[TBL] [Abstract][Full Text] [Related]
12. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran.
Rashidi H; Ramezani Tehrani F; Bahri Khomami M; Tohidi M; Azizi F
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():100-5. PubMed ID: 24411130
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis.
Long C; Feng H; Duan W; Chen X; Zhao Y; Lan Y; Yue R
Front Endocrinol (Lausanne); 2022; 13():980405. PubMed ID: 36120432
[TBL] [Abstract][Full Text] [Related]
14. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.
Huang CC; Tien YJ; Chen MJ; Chen CH; Ho HN; Yang YS
Hum Reprod; 2015 Apr; 30(4):937-46. PubMed ID: 25662806
[TBL] [Abstract][Full Text] [Related]
15. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome - an update.
Boyle J; Teede HJ
Aust Fam Physician; 2012 Oct; 41(10):752-6. PubMed ID: 23210095
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?
Sim SY; Chin SL; Tan JL; Brown SJ; Cussons AJ; Stuckey BG
Fertil Steril; 2016 Oct; 106(5):1258-1263. PubMed ID: 27456547
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovarian syndrome: Prevalence and impact on the wellbeing of Australian women aged 16-29 years.
Varanasi LC; Subasinghe A; Jayasinghe YL; Callegari ET; Garland SM; Gorelik A; Wark JD
Aust N Z J Obstet Gynaecol; 2018 Apr; 58(2):222-233. PubMed ID: 29052216
[TBL] [Abstract][Full Text] [Related]
19. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome.
Joham AE; Ranasinha S; Zoungas S; Moran L; Teede HJ
J Clin Endocrinol Metab; 2014 Mar; 99(3):E447-52. PubMed ID: 24081730
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
